Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asuransi Bina Dana Arta Tbk. (ABDA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Asuransi Bina Dana Arta Tbk.
UBC Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Asuransi Bina Dana Arta Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Asuransi Bina Dana Arta Tbk. trades at Rp3,400 (market cap 2.11T, 1.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Asuransi Bina Dana Arta Tbk. is far larger — about 3.8× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 1.6K). Which is the better fit depends on your goals.

ABDALABS
Market Cap
2.11T556.95B
Volume
1.6K60.83M
Lot
16608.34K
Turnover
5.45M10.26B
Average Price
3,403.75168.64
Value
5.45M10.26B
Indicative Equilibrium Price
152
Indicative Equilibrium Volume
4.52K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABDA
View details
LABS
View details

About Asuransi Bina Dana Arta Tbk.

PT Asuransi Bina Dana Arta Tbk was established at Jakarta under the name of PT Asuransi Bina Dharma Arta, as in accordance with Notarial Deed No. 78 of Kartini Mulyadi, S.H., Notary in Jakarta, dated October 12, 1982.

Read more on ABDA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS